Headway closed a $125 million Series C funding round. The round brings the New York-based startup’s valuation to $1 billion, reaching unicorn status. The company connects patients to in-network therapists and helps mental health providers avoid the massive administrative burden associated with taking insurance.
The four companies are Alma, Headway, NOCD and Ophelia. Alma and Headway will help Empire expand its mental health provider network, while NOCD and Ophelia will address specific conditions: obsessive-compulsive disorder and opioid use disorder, respectively.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Through the collaboration, CareFirst's individual behavioral health practitioners can join Headway's platform so members can filter, choose a provider, book and pay in one spot.
Headway, a startup working to build a network of therapists covered by major insurers, raised $70 million in funding. The startup manages claims, credentialing and other administrative work for independent practices.
The New York based startup is working to build a network of therapists and other mental health providers. It recently raised a $26 million series A round led by Thrive and GV.